nafamostat has been researched along with Pulmonary Embolism in 1 studies
nafamostat: inhibitor of trypsin, plasmin, pancreatic kallikrein, plasma kallikrein & thrombin; strongly inhibits esterolytic activities of C1r & C1 esterase complement-mediated hemolysis; antineoplastic
Pulmonary Embolism: Blocking of the PULMONARY ARTERY or one of its branches by an EMBOLUS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "On the first postoperative day, acute pulmonary thromboembolism (PTE) with occlusion of the pulmonary trunk occurred, and the cardiovascular state became unstable." | 1.33 | [Postoperative acute pulmonary thromboembolism treated with nafamostat mesilate]. ( Nuriya, E; Tsuda, K; Yamada, K; Yamamoto, K, 2006) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tsuda, K | 1 |
| Yamada, K | 1 |
| Yamamoto, K | 1 |
| Nuriya, E | 1 |
1 other study available for nafamostat and Pulmonary Embolism
| Article | Year |
|---|---|
[Postoperative acute pulmonary thromboembolism treated with nafamostat mesilate].
Topics: Aged; Anticoagulants; Benzamidines; Female; Gastrectomy; Guanidines; Humans; Postoperative Complicat | 2006 |